0001437749-14-009329.txt : 20140516 0001437749-14-009329.hdr.sgml : 20140516 20140516090728 ACCESSION NUMBER: 0001437749-14-009329 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140516 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20140516 DATE AS OF CHANGE: 20140516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CATASYS, INC. CENTRAL INDEX KEY: 0001136174 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 880464853 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31932 FILM NUMBER: 14849945 BUSINESS ADDRESS: STREET 1: 11601 WILSHIRE BLVD. STREET 2: SUITE 950 CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 310 444 4300 MAIL ADDRESS: STREET 1: 11601 WILSHIRE BLVD. STREET 2: SUITE 950 CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: HYTHIAM, INC. DATE OF NAME CHANGE: 20101029 FORMER COMPANY: FORMER CONFORMED NAME: HYTHIAM INC DATE OF NAME CHANGE: 20031003 FORMER COMPANY: FORMER CONFORMED NAME: ALASKA FREIGHTWAYS INC DATE OF NAME CHANGE: 20010305 8-K 1 cats20140516_8k.htm FORM 8-K cats20140516_8k.htm

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  May 16, 2014

 

Catasys, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

001-31932

 

88-0464853

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

 

11601 Wilshire Boulevard, Suite 950

Los Angeles, California

 

90025

(Address of principal executive offices)

 

(Zip Code)

     

Registrant’s telephone number, including area code   (310) 444-4300

 

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

 

Item 2.02      Results of Operations and Financial Condition.

 

The information set forth under this “Item 2.02. Results of Operations and Financial Condition,” including the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

On May 16, 2014, Catasys, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended March 31, 2014. The full text of the Company’s press release is furnished herewith as exhibit 99.1.

 

Item 9.01      Financial Statements and Exhibits.

 

(a)     Exhibits.

 

No.

 

 Description

     

99.1

 

Press Release dated May 16, 2014.

     

 

 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

CATASYS, INC.

  

 

 

 

Date: May 16, 2014

 

By:

/s/ SUSAN E. ETZEL

 

 

 

Susan E. Etzel

 

 

 

Chief Financial Officer

 

EX-99 2 ex99-1.htm EXHIBIT 99.1 ex99-1.htm

Exhibit 99.1

 

Catasys Reports Rapid Growth in First Quarter 2014 Results

 

 

88% Increase in Enrollment and 101% Increase in Healthcare Services Revenue

 

LOS ANGELES, May 16, 2014 /PRNewswire/ -- Catasys, Inc. (OTCBB: CATS), provider of proprietary health management services to health insurers and employers, today announced its financial results for the first quarter ended March 31, 2014.

 

Highlights:

 

 

o

CEO Terren Peizer’s total investment in Catasys now exceeds $10 million

 

 

o

88% increase in first quarter enrollment compared with the same quarter last year.

 

 

o

101% increase in recognized revenue from the healthcare services segment to $199,000 in the first quarter, compared with the same quarter last year.

 

 

o

A previously announced agreement with a national health plan, to provide services to its members in New Jersey, is expected to commence enrollment in the third quarter of 2014. Catasys has generated fees from the launched programs and expect to increase enrollment and fees throughout 2014.

 

 

o

Catasys is operating programs in Kansas, Louisiana, Massachusetts, Oklahoma, West Virginia, Kentucky, and Wisconsin. The Wisconsin program, which represents the Company’s first managed care Medicaid health plan customer, commenced enrollment in the first quarter of 2014.

 

 

Rick Anderson, President and COO commented, “During the first quarter, enrollment began for our first managed care Medicaid health plan customer in Wisconsin, enabling us to build our outcomes data in a Medicaid population, and creating a solid opportunity to expand into a national roll out. We regard Medicaid to be a significant and emergent population, as Medicaid plans tend to be plagued with even greater costs of substance dependence than commercial plans.”

 

Mr. Anderson added, “We are pleased that total enrollment and healthcare services revenue continue to grow at an accelerated pace, up 88% and 101%, respectively. As we continue to expand across states with our current customers, launch enrollment for our second national plan, and convert our pipeline of new national and regional plans, we expect this momentum to continue in the upcoming quarters. We believe that Catasys is poised for transformative and profitable growth, both as enrollment reaches a steady state for plans we already have on board, and as we continue to leverage our platform and infrastructure. In the long term, we estimate that our addressable market may grow up to an additional 7-8 times within these existing plans, as we expand to other mental health indications on which we are currently building analytics. Because of high healthcare costs insurance companies face and our savings rates with OnTrak to date we anticipate expanding into these very exciting new areas in the future, affirming the opportunity which lies ahead of us.”

 

Healthcare Services – Overview

 

 

o

Customers – Catasys presently provides its proprietary OnTrak program to health plans in Kansas, Kentucky, Louisiana, Massachusetts, Oklahoma, West Virginia and Wisconsin.

 

 

o

Sales Pipeline and Growth – Management expects continued organic growth – as existing insurers continue to recognize the value of the services of our program and expand into new territories and/or lines of business. Management also expects to continue to grow by signing new insurers. In addition to the signed national insurer, the Company had a sales pipeline of 11.5 million covered lives with 3.7 million in advanced stages of discussion, as of the end of March 31, 2014.

 

 

o

Capital Activity – $1.0 million was raised in January 2014, $919,500 of which was from our CEO Mr. Peizer.

 

 

o

Enrollment – Generally 0.5% of a commercial health plan’s covered lives will be eligible for the OnTrak program and the Company anticipates that approximately 20% of those that are eligible will enroll in the program each year after full enrollment is achieved, which is anticipated up to approximately 12 months from the commencement of enrollment.

 

 

o

Revenues – Healthcare services revenues are generated either monthly based on enrolled members at approximately $8,500 per year, or as a lower case rate when a member enrolls and a share of cost savings realized. Revenue without performance guarantees is recognized ratably over 12 months. If contracts contain a minimum performance guarantee, that portion of the monthly fee subject to the guarantee is reserved as deferred revenue until the performance measurement period is completed. Savings shares are recognized when they are paid.

 

 
 

 

 

First Quarter 2014 Results of Operations

 

For the first quarter of fiscal 2014, total revenues increased 61% to $218,000 compared with $135,000 for the same period last year. Increased total revenues are primarily a result of an increase in healthcare services revenue. The Company reported income from operations before income taxes of $2.1 million, or $0.11 per basic share and $0.08 per diluted share, for the first quarter of 2014, compared with income from operations before income taxes of $2.6 million, or $0.22 per basic share and $0.16 per diluted share, in the first quarter last year. The financial statements have been retroactively restated to reflect the 10-for-1 reverse stock split that occurred on May 6, 2013.

 

Total operating expenses for the first quarter of 2014 were $1.8, essentially unchanged, when compared with the first quarter in 2013.

 

OnTrak Program
Catasys' OnTrak program – contracted with a growing number of health insurers – is designed to improve member health and at the same time lower costs to the insurer by utilizing member engagement and patient centric treatment that integrates evidence based medical and psychosocial interventions along with care coaching in a 52-week outpatient program. OnTrak is currently improving member health and, at the same time, is demonstrating reduced inpatient and emergency department utilization driving a more than 50 percent reduction in total health care costs for enrolled members.

 

About Catasys, Inc.
Catasys, Inc. provides specialized health management services to health plans and employers through a network of licensed and company managed health care providers. The Catasys substance dependence program improves member health, thereby lowering overall costs. The proprietary program addresses substance dependence as a chronic disease, focusing on the whole health of the member. The program delivers integrated medical and psychosocial interventions in combination with long-term care coaching. For further information, please visit 
www.catasys.com.

 

Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, changes in regulations or issuance of new regulations or interpretations, limited operating history, our inability to execute our business plan and achieve profitability, lack of outcomes and statistically significant formal research studies, difficulty enrolling members in our programs, the risk that treatment programs might not be effective, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the health care industry and our liquidity. You are urged to consider statements that include the words "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plan," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties we face, please refer to our most recent Securities and Exchange Commission filings which are available on its website at 
http://www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

 

 

Investor Contact:

James Carbonara, Regional Vice President

Hayden IR

Email:

Phone: 646-755-7412

 

 
 

 

 

CATASYS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

 

   

Three Months Ended

 

(In thousands, except per share amounts)

 

March 31,

 
   

2014

   

2013

 

Revenues

               

Healthcare services revenues

  $ 199     $ 99  

License and management services revenues

    19       36  

Total revenues

  $ 218     $ 135  
                 

Operating expenses

               

Cost of healthcare services

  $ 333     $ 204  

General and administrative

    1,505       1,629  

Depreciation and amortization

    28       47  

Total operating expenses

  $ 1,866     $ 1,880  
                 

Loss from operations

  $ (1,648 )   $ (1,745 )
                 

Interest expense

    (1,312 )     -  

Change in fair value of warrant liability

    5,101       4,360  

Income from operations before provision for income taxes

  $ 2,141     $ 2,615  

Provision for income taxes

    2       2  

Net Income

  $ 2,139     $ 2,613  
                 

Basic and diluted net income per share:*

               

Basic net income per share*

  $ 0.11     $ 0.22  
                 

Basic weighted number of shares outstanding*

    19,449       12,057  
                 

Diluted net income per share*

  $ 0.08     $ 0.16  
                 

Diluted weighted number of shares outstanding*

    28,166       16,562  

 

* The financial statements have been retroactively restated to reflect the 10-for-1 reverse stock split that occurred on May 6, 2013.

 

 
 

 

 

CATASYS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   

March 31,

         

(In thousands, except for number of shares)

 

2014

   

December 31,

 
   

(unaudited)

   

2013

 

ASSETS

               

Current assets

               

Cash and cash equivalents

  $ 723     $ 1,136  

Receivables, net of allowance for doubtful accounts of $13 and $0, respectively

    293       173  

Receivables from related party

    -       115  

Prepaids and other current assets

    230       275  

Total current assets

    1,246       1,699  

Long-term assets

               

Property and equipment, net of accumulated depreciation of $2,014 and $2,001, respectively

    380       366  

Intangible assets, net of accumulated amortization of $406 and $401, respectively

    113       118  

Deposits and other assets

    353       440  

Total Assets

  $ 2,092     $ 2,623  
                 

LIABILITIES AND STOCKHOLDERS' DEFICIT

               

Current liabilities

               

Accounts payable

  $ 1,072     $ 1,148  

Accrued compensation and benefits

    1,205       1,181  

Deferred revenue

    684       534  

Other accrued liabilities

    1,204       1,270  

Total current liabilities

    4,165       4,133  

Long-term liabilities

               

Deferred rent and other long-term liabilities

    238       160  

Capital leases

    24       26  

Warrant liabilities

    13,556       16,347  

Total Liabilities

    17,983       20,666  
                 

Stockholders' deficit

               

Preferred stock, $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding

    -       -  

Common stock, $0.0001 par value; 500,000,000 shares authorized at March 31, 2014 and December 31, 2013, respectively; 20,559,712 and 18,835,571 shares issued and outstanding at March 31, 2014 and December 31, 2013, respectively

    2       2  

Additional paid-in-capital

    209,182       209,169  

Accumulated deficit

    (225,075 )     (227,214 )

Total Stockholders' deficit

    (15,891 )     (18,043 )

Total Liabilities and Stockholders' deficit

  $ 2,092     $ 2,623  

 

* The financial statements have been retroactively restated to reflect the 10-for-1 reverse stock split that occurred on May 6, 2013.